Brain Cancer
Frontal Lobe Astrocytoma
Male, 38 years
Patient Internal 146903545
ICD-10 code
C71.1 Malignant Neoplasm of the Frontal Lobe
Diagnosis (Incl. Metastases/Stage) and Year
June 2019
High-grade Malignant Astrocytoma of the Frontal Lobe G2, IDH1 mutated. March 2020 – Tumour Recurrence: Brain Anaplastic Astrocytoma G3, IDH1 and ATRX mutated, Ki67 – 20%. Recraniotomy, Tumour Removal (08-04-2020).
Previous Treatment
Surgery (craniotomy), chemotherapy (Temozolomide).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of 33 months from diagnosis.
Treatment Provided
Autologous DCV (10 doses) and CIK (4 doses) over a period of 14 months.
Additionally, the patient received nasal drops of exosomes with Paclitaxel.
Patient Survival/Condition and Year
Date of Review: 15/10/2023
The patient is alive (now 52 months since diagnosis) with stable disease.
It can be concluded that the addition of Immunotherapy, alongside Surgery and Chemotherapy, has extended
the patient’s survival by about 1 and a half years so far, compared with median survival.
